Evidence map›Paper›PMID 20133941›Full record

ArticleThe Journal of biological chemistry2010

The inorganic pyrophosphate transporter ANK preserves the differentiated phenotype of articular chondrocyte.

Frederic Cailotto, Sylvie Sebillaud, Patrick Netter, Jean-Yves Jouzeau, Arnaud Bianchi

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Frederic CailottoLaboratoire de Physiopathologie, Pharmacologie et Ingénierie Articulaires, UMR 7561 CNRS-Nancy-Université, Avenue de la Forêt de Haye, BP184, 54505 Vandoeuvre-Lès-Nancy, France. frederic.cailotto@hotmail.fr
Sylvie Sebillaud
Patrick Netter
Jean-Yves Jouzeau
Arnaud Bianchi
Ingénierie Moléculaire et Physiopathologie Articulaire · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The differentiated phenotype of chondrocyte is lost in pathological situations and after interleukin (IL)-1beta challenge. Wnt proteins and the inorganic pyrophosphate (PP(i)) transporter Ank regulate the differentiation process in many cell types. We investigated the possible contribution of Ank and/or PP(i) to the maintenance of the differentiated chondrocyte phenotype with special care to Wnt signaling. Primary articular chondrocytes lost their phenotype upon IL-1beta challenge, with cessation of type II collagen and Sox-9 expression. Ank expression and PP(i) transport were strongly reduced by IL-1beta, whereas Wnt-5a was the only Wnt protein increased. Transient overexpression of Ank counteracted most of IL-1beta effects on Type II collagen, Sox-9, and Wnt-5a expression. When resting chondrocytes were transfected with a siRNA against Ank, this reproduced the phenotype induced by IL-1beta. In both cases, no markers for hypertrophic chondrocytes were detected. The conditioned supernatant from chondrocytes knocked-down for Ank contained Wnt-5a, which activated Tcf/Lef reporter plasmids and promoted translocation of beta-catenin into the nucleus without activating the c-Jun N-terminal kinase (JNK) pathway. Supplementation with PP(i) compensated for most effects of Ank deficiency on Type II collagen, Sox-9, and Wnt-5 expression, both in IL-1beta and Ank knock-down conditions. Phenotype changes induced by IL-1beta were also supported by activation of the JNK pathway, but this latter was not sensitive to PP(i) supplementation. Altogether our data demonstrate that the transport of PP(i) by ANK contributed to the maintenance of the differentiated phenotype of chondrocyte by controlling the canonical Wnt pathway in a Wnt-5a-dependent manner.

Indexed as

PhenotypeSignal TransductionAnimalsbeta CateninCartilage, ArticularCell DifferentiationCells, CulturedChondrocytesCollagen Type IICulture Media, ConditionedDiphosphatesInterleukin-1betaJNK Mitogen-Activated Protein KinasesMaleMembrane ProteinsPhosphate Transport ProteinsAnkh protein, mousebeta CateninCollagen Type IICulture Media, ConditionedDiphosphatesInterleukin-1betaJNK Mitogen-Activated Protein KinasesMembrane ProteinsPhosphate Transport ProteinsRNA, Small InterferingSOX9 Transcription FactorWnt Proteins

Identifiers

PMID20133941
PMCPMC2856265
OpenAlexW1963629215

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.